Drug intelligence / Profile preview

N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide

Development stage
Unknown
Lead developer
Knight Therapeutics
Modality
Small Molecules
01

Overview

N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide is a synthetic small molecule with the molecular formula C20H20ClN3S and a molecular weight of approximately 369.9 g/mol[1][6][7]. It is primarily used as a research tool and not approved for clinical or therapeutic use[2][3]. The compound is known to act as an inhibitor of nitric oxide synthase (NOS), including isoforms such as neuronal NOS (nNOS/NOS1), endothelial NOS (eNOS/NOS3), and inducible NOS (iNOS)[1]. Its mechanism involves binding to the active site of these enzymes, thereby inhibiting the production of nitric oxide, which plays roles in neurotransmission, vascular regulation, and immune response. The compound has been studied structurally in protein-ligand complexes but has no reported clinical development or approved indications.

Other names
N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamideN′-[4-[2-[(3-chlorophenyl)methylamino]ethyl]phenyl]thiophene-2-carboximidamideN-(4-(2-((3-chlorophenylmethyl)amino)ethyl)phenyl)-2-thiophenecarboxamidine866914-87-6
02

Targets

NOS1 (nNOS)NOS3 (eNOS)NOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call